Experimental study demonstrates sensitive detection of 3-nitrotyrosine in urine and serum, highlighting its clinical utility as a selective luminescent sensor.
Based on the mixed ligands of 1,4‐bis(2,4,6‐tricarboxylpyrid‐5‐yl)benzene (H 6 BTPB) and 1,4‐bis(imidazol‐1‐yl)benzene (bib), a new cadmium(II) coordination polymer with the molecular formula of {[Cd(bib)( μ 2 ‐H 2 O)(H 2 O) 2 ](H 4 BTPB) 0.5 (bib) 0.5 } n (CdCP) was constructed under solvothermal condition, and displayed a 3D supramolecular structure expanded by the hydrogen bonds between the 1D [Cd(bib)( μ 2 ‐H 2 O)(H 2 O) 2 ] n ladder chain and the guests. Profiting from its superior stability and inherent luminescence, the prepared CdCP dispalyed great potential as a highly sensitive and selective luminescent sensor in trace detection of 3‐NT biomarker in both water and real bodily fluids through the luminescence quenching effects, with the K sv and LODs being 2.408×10 5 M −1 and 30.3 nM in water, 2.230×10 5 M −1 and 44.7 nM in diluted urine, 2.249×10 5 M −1 and 43.9 nM in diluted serum, respectively. Subsequent mechanism studies indicated the synergistic effect of internal filtering effect, photo‐induced electron transfer, and fluorescence resonance energy transfer determining the luminescence quenching response of CdCP towards 3‐NT biomarker.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: